ARCHIVES

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

This article is from The Cancer Letter archive.

Vol. 21 No. 15 | April 14, 1995

Download PDF Visit The Full Archive

Related Articles

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says

January 31, 1997

In Brief: Judge Declines To Block NCI Contract Award

February 24, 1995

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981